U.S. pharma large copyright scrapped two experimental weight loss pills previous yr—a at the time-day-to-day pill, lotiglipron, due to elevated liver enzymes along with a twice-day-to-day tablet, danuglipron, on account of solid Unwanted side effects—but CEO Albert Bourla has reporte